Blind mole rats resist cancer by killing cells that proliferate in a similar way to tumor cells.
The Scientist
Most Recent
Biotech, pharmaceutical, and insurance companies have spent a record-breaking amount this election—nearly $200 million.
Recording brain activity as patients are anesthetized for surgery, researchers identify a pattern that may signal loss of consciousness.
Researchers identify an unexpected molecular explanation for the higher incidence of skin cancer in redheads.
Retracting a paper from the scientific literature can lead to fewer citations for related studies.
Contributors
| November 1, 2012
Meet some of the people featured in the November 2012 issue of The Scientist.
Despite abundant evidence supporting their ability to help prevent and treat cardiovascular disease, the therapeutic effectiveness of fish oil–derived fatty acids remains controversial.
First, Aravinda Chakravarti drew a map of how scientists might unravel the genetics of complex disease. Then he blazed the trail.
After two headline successes, companies rush to develop “smart bomb” cancer drugs.
Researcher salaries continue to buck the trend of the millennium’s first decade, remaining flat or even declining across most life science disciplines.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
